Statement on dual use of AI drug discovery
March 18, 2022 — Stances
The VMind team
— —
At the heart of VMind is a fiduciary pledge to commit artificial intelligence (AI) for the sake and use of humanity, and never for its harm.

We read with dismay the alarming recent report by Urbina et al. alerting of the potential misuse of AI drug discovery models for bioweapons development (Dual use of artificial-intelligence-powered drug discovery. Nat Mach Intell. 2022).

In agreence with our pledge, at VMind we commit to work with our commercial partners to secure all our AI assets in drug discovery against misuse or bioweaponization, accidental or not.

We call the techbio and pharma industry to pledge to do the same.
— —
Published
March 18, 2022
Acknowledgments
Thanks to Jabran Chaudry (University of Glasgow) for comments.
Citation
VMind Technologies. "Preventing dual use of AI-driven drug discovery", VMind Blog, March 18, 2022. URL: https://www.vmindai.com/blog/statement-on-dual-use-of-ai-drug-discovery